General - Press Releases

Date	Title	Company
14-Mar-2023	Onxeo Will Publish Its Full-year Results on April 14, 2023	Businesswire
14-Mar-2023	CXL Ophthalmics Appoints Tiffany Haynes as Vice President of Clinical Operations	Businesswire
14-Mar-2023	New Analysis of MRI Findings Show UPLIZNA® (inebilizumab-cdon) Reduced the Formation of Asymptomatic Optic Nerve Lesions in People With Neuromyelitis Optica Spectrum Disorder (NMOSD)	Businesswire
14-Mar-2023	Market Disruptor Axion BioSystems Rejects Agilent Technologies, Inc. Allegations	Businesswire
14-Mar-2023	Self-Excitation Piezo Sounder Driver from Diodes Incorporated Extends Runtime and Maintains High SPL Output Across Entire Battery Life	Businesswire
14-Mar-2023	Andersen Global Adds Valuation Capabilities in Romania	Businesswire
14-Mar-2023	NanoVibronix Announces Positive Results from Independent Product Trial of UroShield for Patients with a Spinal Cord Injury	Businesswire
14-Mar-2023	Sengenics Corporation Announces Fredrik Sundberg as New Vice President of Market and Business Development	Businesswire
14-Mar-2023	FSD Pharma (Symbol: HUGE) Renews Shareholder Intelligence Services to Investigate Possible Naked Short Selling and Appeals to The Regulators and Oversight Bodies to Look Into The Short Selling Activity Of Its Stock	Businesswire
14-Mar-2023	Puma Biotechnology Announces Publication of Phase II Clinical Trial of Alisertib in JAMA Oncology	Businesswire
14-Mar-2023	Oragenics Announces Positive Results in Several Lantibiotics Compounds Against MRSA and VRE	Businesswire
14-Mar-2023	Eureka Therapeutics Licenses Promising Antibody Targeting Mesothelin from the National Cancer Institute	Businesswire
14-Mar-2023	Aiosyn Launches AI-powered Automated Quality Control to Improve the Digital Pathology Workflow	Businesswire
14-Mar-2023	Direct Biologics Reports Compelling Results From Phase 2 Trial With ExoFlo™ in Hospitalized Patients With Respiratory Failure or Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19	Businesswire
14-Mar-2023	Global Clinical Trial Activity Remained Resilient in 2022 Despite The Continued Pandemic, Says IQVIA Institute	Businesswire
14-Mar-2023	Vesigen Therapeutics Awarded Grant from Friedreich’s Ataxia Research Alliance (FARA) to Develop a Targeted Genome Editing Therapeutic Strategy	Businesswire
14-Mar-2023	Catamaran Bio selects OmniaBio as partner to develop and manufacture allogeneic CAR-NK cell therapies	Businesswire
14-Mar-2023	AutoCruitment Adds to Executive Team; Opens New Raleigh, North Carolina, Office	Businesswire
14-Mar-2023	Physicians are Jaded, Burned Out and Worried, Yet Show Glimmers of Optimism around Pricing and Innovation, Says 2023 Apollo Intelligence Global Healthcare Report	Businesswire
14-Mar-2023	Enveric Biosciences Announces Bioproduction Platform Using Novel Cane Toad Enzyme for Psychedelic-Inspired Drug Discovery	Businesswire